Citation Tools

Download PDFPDF

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

Download to a citation manager

Cite this article as:
Buchbinder EI, Dutcher JP, Daniels GA, et al
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition